Select Medical Holdings Co. (NYSE:SEM) Stock Holdings Reduced by Gotham Asset Management LLC

Gotham Asset Management LLC lessened its stake in shares of Select Medical Holdings Co. (NYSE:SEM) by 13.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,142 shares of the health services provider’s stock after selling 3,093 shares during the quarter. Gotham Asset Management LLC’s holdings in Select Medical were worth $380,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in SEM. Barclays PLC boosted its stake in shares of Select Medical by 396.0% during the 3rd quarter. Barclays PLC now owns 192,357 shares of the health services provider’s stock worth $6,707,000 after acquiring an additional 153,576 shares in the last quarter. Inspire Investing LLC boosted its stake in shares of Select Medical by 78.6% during the 4th quarter. Inspire Investing LLC now owns 21,258 shares of the health services provider’s stock worth $401,000 after acquiring an additional 9,355 shares in the last quarter. CX Institutional boosted its stake in shares of Select Medical by 8.9% during the 4th quarter. CX Institutional now owns 37,904 shares of the health services provider’s stock worth $714,000 after acquiring an additional 3,083 shares in the last quarter. Linden Thomas Advisory Services LLC boosted its stake in shares of Select Medical by 16.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 25,576 shares of the health services provider’s stock worth $482,000 after acquiring an additional 3,541 shares in the last quarter. Finally, KBC Group NV boosted its stake in shares of Select Medical by 14.0% during the 4th quarter. KBC Group NV now owns 14,883 shares of the health services provider’s stock worth $281,000 after acquiring an additional 1,833 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on SEM. Mizuho assumed coverage on Select Medical in a research note on Wednesday, April 16th. They set an “outperform” rating and a $25.00 price target for the company. Royal Bank of Canada cut their price objective on Select Medical from $23.00 to $19.00 and set an “outperform” rating for the company in a research report on Wednesday, May 7th. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Finally, Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective for the company in a research report on Monday, February 24th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.00.

Insider Transactions at Select Medical

In other news, CEO David S. Chernow sold 225,000 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer now directly owns 714,516 shares of the company’s stock, valued at approximately $12,861,288. This represents a 23.95% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Parvinderjit S. Khanuja purchased 21,000 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The shares were acquired at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the completion of the transaction, the director now owns 65,089 shares in the company, valued at $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. 11.60% of the stock is currently owned by insiders.

Select Medical Trading Down 0.6%

Select Medical stock opened at $15.11 on Wednesday. The business has a 50 day moving average price of $16.28 and a two-hundred day moving average price of $20.27. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $1.94 billion, a price-to-earnings ratio of 9.16, a price-to-earnings-growth ratio of 0.64 and a beta of 1.40. Select Medical Holdings Co. has a 12 month low of $14.03 and a 12 month high of $40.98.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.40 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company’s revenue was down 24.4% on a year-over-year basis. During the same period last year, the company earned $0.75 EPS. As a group, equities analysts forecast that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be issued a $0.0625 dividend. The ex-dividend date is Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.65%. Select Medical’s payout ratio is presently 18.66%.

Select Medical announced that its board has approved a share buyback program on Thursday, May 1st that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.